These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11123810)

  • 1. Retrospective follow-up of recipients and donors of blood donations reactive for anti-HBc or for single HCV antibodies.
    Howell DR; Webster MH; Barbara JA
    Transfus Med; 2000 Dec; 10(4):265-9. PubMed ID: 11123810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of anti-HBc screening of blood donors and its association with occult hepatitis B virus infection: Implications for blood transfusion.
    Asim M; Ali R; Khan LA; Husain SA; Singla R; Kar P
    Indian J Med Res; 2010 Sep; 132():312-7. PubMed ID: 20847378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Significance of alanine aminotransferase screening in blood donors for risk reduction of hepatitis B and C transmission by haemotherapy].
    Kusendová K; Gavorník P; Sabaka P; Sviteková K
    Vnitr Lek; 2016 Jan; 62(1):9-16. PubMed ID: 26967232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B virus DNA-positive, hepatitis B surface antigen-negative blood donations intercepted by anti-hepatitis B core antigen testing: the Canadian Blood Services experience.
    O'Brien SF; Fearon MA; Yi QL; Fan W; Scalia V; Muntz IR; Vamvakas EC
    Transfusion; 2007 Oct; 47(10):1809-15. PubMed ID: 17880605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of serologic markers for hepatitis B and C viruses in Brazilian blood donors and incidence and residual risk of transfusion transmission of hepatitis C virus.
    de Almeida-Neto C; Sabino EC; Liu J; Blatyta PF; Mendrone-Junior A; Salles NA; Leão SC; Wright DJ; Basques FV; Ferreira JE; Busch MP; Murphy EL;
    Transfusion; 2013 Apr; 53(4):827-34. PubMed ID: 22882510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Investigation of the presence of HBV-DNA in isolated anti-HBc positive cases and their importance in blood banking].
    Bal SH; Heper Y; Kumaş LT; Mistik R; Töre O
    Mikrobiyol Bul; 2009 Apr; 43(2):243-50. PubMed ID: 19621609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significant increase in HBV, HCV, HIV and syphilis infections among blood donors in West Bengal, Eastern India 2004-2005: exploratory screening reveals high frequency of occult HBV infection.
    Bhattacharya P; Chandra PK; Datta S; Banerjee A; Chakraborty S; Rajendran K; Basu SK; Bhattacharya SK; Chakravarty R
    World J Gastroenterol; 2007 Jul; 13(27):3730-3. PubMed ID: 17659734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
    Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
    Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-HBc screening - is it worth the effort? Results of a 10-year surveillance programme covering more than 30 million donations in Germany.
    Houareau C; Offergeld R
    Vox Sang; 2019 Jul; 114(5):459-466. PubMed ID: 30968958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that anti-HBc but not HBV DNA testing may prevent some HBV transmission by transfusion.
    Allain JP; Hewitt PE; Tedder RS; Williamson LM
    Br J Haematol; 1999 Oct; 107(1):186-95. PubMed ID: 10520040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolated anti-HBc-IgM antibody among blood donors in the semi-arid region of Nigeria.
    Jeremiah ZA; Idris H; Ajayi BB; Ezimah AC; Malah MB; Baba MM
    Hum Antibodies; 2011; 20(3-4):77-82. PubMed ID: 22129677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection and significance of anti-HBc in the blood bank; preliminary results of a controlled prospective study.
    Katchaki JN; Siem TH; Brouwer R; Brandt KH; van der Waart M
    J Virol Methods; 1980 Dec; 2(1-2):119-25. PubMed ID: 7228974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NAT for HBV and anti-HBc testing increase blood safety.
    Roth WK; Weber M; Petersen D; Drosten C; Buhr S; Sireis W; Weichert W; Hedges D; Seifried E
    Transfusion; 2002 Jul; 42(7):869-75. PubMed ID: 12375659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population.
    Prieto M; Gómez MD; Berenguer M; Córdoba J; Rayón JM; Pastor M; García-Herola A; Nicolás D; Carrasco D; Orbis JF; Mir J; Berenguer J
    Liver Transpl; 2001 Jan; 7(1):51-8. PubMed ID: 11150423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection.
    Behzad-Behbahani A; Mafi-Nejad A; Tabei SZ; Lankarani KB; Torab A; Moaddeb A
    Indian J Med Res; 2006 Jan; 123(1):37-42. PubMed ID: 16567866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of antibodies to hepatitis B core antigen and occult hepatitis B virus infections in Korean blood donors.
    Seo DH; Whang DH; Song EY; Kim HS; Park Q
    Transfusion; 2011 Aug; 51(8):1840-6. PubMed ID: 21332731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value?
    Stramer SL; Zou S; Notari EP; Foster GA; Krysztof DE; Musavi F; Dodd RY
    Transfusion; 2012 Feb; 52(2):440-6. PubMed ID: 21810101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of screening antibodies to hepatitis B virus core antigen among Syrian blood donors.
    Muselmani W; Habbal W; Monem F
    Transfus Med; 2013 Aug; 23(4):265-8. PubMed ID: 23621787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ten-year follow-up study of hepatitis B virus infection and vaccination status in hospital employees.
    Rosen E; Rudensky B; Paz E; Isacsohn M; Jerassi Z; Gottehrer NP; Yinnon AM
    J Hosp Infect; 1999 Mar; 41(3):245-50. PubMed ID: 10204128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Investigation of HBV-DNA using the polymerase chain reaction (PCR) in HBsAg-negative, anti-HBc-positive Venezuelan donors].
    León G; López JL; Maio A; García L; Quiroz AM
    Sangre (Barc); 1999 Oct; 44(5):342-6. PubMed ID: 10618910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.